CSPC Pharmaceutical Group Limited — Earnings Release 2004

Apr 11, 2005

Listed Company Information

Listed Company Information
CHINA PHARMA<01093> - Results Announcement China Pharmaceutical Group Limited announced on 11/04/2005: (stock code: 01093 ) Year end date: 31/12/2004 Currency: HKD Auditors' Report: Unqualified (Audited ) (Audited ) Last Current Corresponding Period Period from 01/01/2004 from 01/01/2003 to 31/12/2004 to 31/12/2003 Note ('000 ) ('000 ) Turnover : 2,450,649 2,478,426 Profit/(Loss) from Operations : 273,117 618,289 Finance cost : (27,959) (25,361) Share of Profit/(Loss) of Associates : N/A N/A Share of Profit/(Loss) of Jointly Controlled Entities : 4,008 7,610 Profit/(Loss) after Tax & MI : 245,011 504,169 % Change over Last Period : -51 % EPS/(LPS)-Basic (in dollars) : 0.1593 0.3327 -Diluted (in dollars) : N/A 0.3283 Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : 245,011 504,169 Final Dividend : Nil 7.0 cents per Share (Specify if with other : N/A N/A options) B/C Dates for Final Dividend : N/A Payable Date : N/A B/C Dates for (-) General Meeting : N/A Other Distribution for : N/A Current Period B/C Dates for Other Distribution : N/A Remarks: 1. Profit from operations 2004 2003 HK$'000 HK$'000 Profit from operations has been arrived at after charging (crediting): Amortisation of intangible assets 12,405 13,770 Amortisation of goodwill 3,183 3,168 Depreciation of property, plant and equipment 168,236 129,024 Bank interest income (2,454) (1,589) ======= ======= 2. Earnings per share The calculation of basic earnings per share for the year ended December 31, 2004 is based on the net profit for the year of HK$245,011, 000 and the 1,538,124,661 shares in issue during the year. No diluted earnings per share was presented for the year ended December 31, 2004 as there was no potential ordinary shares in issue during the year. The calculation of basic and diluted earnings per share for the year ended December 31, 2003 was based on the following data: 2003 Profit attributable to shareholders HK$504,169,000 =============== Weighted average number of ordinary shares for the purposes of basic earnings per share 1,515,192,387 Effect of dilutive potential ordinary shares in respect of share options 20,501,401 ______________ Weighted average number of ordinary shares for the purposes of diluted earnings per share 1,535,693,788 ==============